Piramal Critical care Limited

SMEUK · West DraytonCompany No. 05160306

Piramal Critical care Limited is a UK limited company, based in West Drayton, incorporated in 2004. Has won 38 UK public-sector contracts worth £421.5m across 8 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£403.7m

new

Public buyers

stable this month

Top buyer share

99%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 99% of revenue.

NHS England

£419.2m

99%

Department of Health and Social Care (DHSC)

£1.4m

NHS England and NHS Improvement

£944k

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

Department of Health & Social Care

—

Contracts won · 38 total · 31 active · 6 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£403.7m lot total · 104 suppliers	13 Jan 2026	pending
Intravenous (IV) Fluids, Topical Solutions, Urological Solutions and Gelatins	NHS England	Shared contract	£6.8m lot total · 7 suppliers	28 Jun 2021	expired
NHS National Generic Pharmaceuticals - Inhalation Anaesthetics and Vaporisers	NHS England	Shared contract	£6.5m lot total · 4 suppliers	25 Jan 2021	expired
NHS National Generic Pharmaceuticals Wave 14a	NHS England	Shared contract	£2.1m lot total · 99 suppliers	14 Dec 2022	expired
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)	Department of Health and Social Care (DHSC)	Shared contract	£1.0m lot total · 16 suppliers	11 Nov 2020	expired
NHS National Pharmaceuticals Transition 2022_1	NHS England and NHS Improvement	Framework call off	£944k ceiling · ~£22k share (÷42)	19 Jul 2022	expired
Supportive Medicines including ITU, EOL & Antibiotics	Department of Health and Social Care (DHSC)	Shared contract	£382k lot total · 4 suppliers	17 Sept 2020	expired
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)	NHS England	Shared contract	£0.02 lot total · 63 suppliers	04 Mar 2024	active
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	— lot total · 104 suppliers	—	active
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 37 suppliers	—	active
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)Open Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)	Department of Health & Social Care	Direct contract	—	—	active
NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers	NHS England	Direct contract	—	—	active
NHS National Generic Pharmaceuticals Wave 15b	NHS England	Direct contract	—	—	active
Generic Drugs – Topicals & Miscellaneous	Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)	Direct contract	—	—	active
Generic Drugs - Injections/Infusions	Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)	Direct contract	—	—	active

Showing 1–15 of 38

Piramal Critical care Limited

Buyer concentration

Contracts won · 38 total · 31 active · 6 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Piramal Critical care Limited

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive